Cargando…

What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss

PURPOSE: Glaucoma patients with peripheral vision loss have in the past subjectively described their field loss as ‘blurred’ or ‘no vision compromise’. We developed an iPad app for patients to self-characterise perception within areas of glaucomatous visual field loss. METHODS: Twelve glaucoma patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagrani, Meghal, Ndulue, Jideofor, Anderson, David, Kedar, Sachin, Gulati, Vikas, Shepherd, John, High, Robin, Smith, Lynette, Fowler, Zachary, Khazanchi, Deepak, Nawrot, Mark, Ghate, Deepta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788032/
https://www.ncbi.nlm.nih.gov/pubmed/33218992
http://dx.doi.org/10.1136/bjophthalmol-2020-317034
_version_ 1784639471978807296
author Gagrani, Meghal
Ndulue, Jideofor
Anderson, David
Kedar, Sachin
Gulati, Vikas
Shepherd, John
High, Robin
Smith, Lynette
Fowler, Zachary
Khazanchi, Deepak
Nawrot, Mark
Ghate, Deepta
author_facet Gagrani, Meghal
Ndulue, Jideofor
Anderson, David
Kedar, Sachin
Gulati, Vikas
Shepherd, John
High, Robin
Smith, Lynette
Fowler, Zachary
Khazanchi, Deepak
Nawrot, Mark
Ghate, Deepta
author_sort Gagrani, Meghal
collection PubMed
description PURPOSE: Glaucoma patients with peripheral vision loss have in the past subjectively described their field loss as ‘blurred’ or ‘no vision compromise’. We developed an iPad app for patients to self-characterise perception within areas of glaucomatous visual field loss. METHODS: Twelve glaucoma patients with visual acuity ≥20/40 in each eye, stable and reliable Humphrey Visual Field (HVF) over 2 years were enrolled. An iPad app (held at 33 cm) allowed subjects to modify ‘blur’ or ‘dimness’ to match their perception of a 2×2 m wall-mounted poster at 1 m distance. Subjects fixated at the centre of the poster (spanning 45° of field from centre). The output was degree of blur/dim: normal, mild and severe noted on the iPad image at the 54 retinal loci tested by the HVF 24-2 and was compared to threshold sensitivity values at these loci. Monocular (Right eye (OD), left eye (OS)) HVF responses were used to calculate an integrated binocular (OU) visual field index (VFI). All three data sets were analysed separately. RESULTS: 36 HVF and iPad responses from 12 subjects (mean age 71±8.2y) were analysed. The mean VFI was 77% OD, 76% OS, 83% OU. The most common iPad response reported was normal followed by blur. No subject reported dim response. The mean HVF sensitivity threshold was significantly associated with the iPad response at the corresponding retinal loci (For OD, OS and OU, respectively (dB): normal: 23, 25, 27; mild blur: 18, 16, 22; severe blur: 9, 9, 11). On receiver operative characteristic (ROC) curve analysis, the HVF retinal sensitivity cut-off at which subjects reported blur was 23.4 OD, 23 OS and 23.3 OU (dB). CONCLUSIONS: Glaucoma subjects self-pictorialised their field defects as blur; never dim or black. Our innovation allows translation of HVF data to quantitatively characterise visual perception in patients with glaucomatous field defects.
format Online
Article
Text
id pubmed-8788032
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87880322022-02-07 What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss Gagrani, Meghal Ndulue, Jideofor Anderson, David Kedar, Sachin Gulati, Vikas Shepherd, John High, Robin Smith, Lynette Fowler, Zachary Khazanchi, Deepak Nawrot, Mark Ghate, Deepta Br J Ophthalmol Clinical Science PURPOSE: Glaucoma patients with peripheral vision loss have in the past subjectively described their field loss as ‘blurred’ or ‘no vision compromise’. We developed an iPad app for patients to self-characterise perception within areas of glaucomatous visual field loss. METHODS: Twelve glaucoma patients with visual acuity ≥20/40 in each eye, stable and reliable Humphrey Visual Field (HVF) over 2 years were enrolled. An iPad app (held at 33 cm) allowed subjects to modify ‘blur’ or ‘dimness’ to match their perception of a 2×2 m wall-mounted poster at 1 m distance. Subjects fixated at the centre of the poster (spanning 45° of field from centre). The output was degree of blur/dim: normal, mild and severe noted on the iPad image at the 54 retinal loci tested by the HVF 24-2 and was compared to threshold sensitivity values at these loci. Monocular (Right eye (OD), left eye (OS)) HVF responses were used to calculate an integrated binocular (OU) visual field index (VFI). All three data sets were analysed separately. RESULTS: 36 HVF and iPad responses from 12 subjects (mean age 71±8.2y) were analysed. The mean VFI was 77% OD, 76% OS, 83% OU. The most common iPad response reported was normal followed by blur. No subject reported dim response. The mean HVF sensitivity threshold was significantly associated with the iPad response at the corresponding retinal loci (For OD, OS and OU, respectively (dB): normal: 23, 25, 27; mild blur: 18, 16, 22; severe blur: 9, 9, 11). On receiver operative characteristic (ROC) curve analysis, the HVF retinal sensitivity cut-off at which subjects reported blur was 23.4 OD, 23 OS and 23.3 OU (dB). CONCLUSIONS: Glaucoma subjects self-pictorialised their field defects as blur; never dim or black. Our innovation allows translation of HVF data to quantitatively characterise visual perception in patients with glaucomatous field defects. BMJ Publishing Group 2022-02 2020-11-27 /pmc/articles/PMC8788032/ /pubmed/33218992 http://dx.doi.org/10.1136/bjophthalmol-2020-317034 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Clinical Science
Gagrani, Meghal
Ndulue, Jideofor
Anderson, David
Kedar, Sachin
Gulati, Vikas
Shepherd, John
High, Robin
Smith, Lynette
Fowler, Zachary
Khazanchi, Deepak
Nawrot, Mark
Ghate, Deepta
What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss
title What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss
title_full What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss
title_fullStr What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss
title_full_unstemmed What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss
title_short What do patients with glaucoma see: a novel iPad app to improve glaucoma patient awareness of visual field loss
title_sort what do patients with glaucoma see: a novel ipad app to improve glaucoma patient awareness of visual field loss
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788032/
https://www.ncbi.nlm.nih.gov/pubmed/33218992
http://dx.doi.org/10.1136/bjophthalmol-2020-317034
work_keys_str_mv AT gagranimeghal whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss
AT nduluejideofor whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss
AT andersondavid whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss
AT kedarsachin whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss
AT gulativikas whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss
AT shepherdjohn whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss
AT highrobin whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss
AT smithlynette whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss
AT fowlerzachary whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss
AT khazanchideepak whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss
AT nawrotmark whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss
AT ghatedeepta whatdopatientswithglaucomaseeanovelipadapptoimproveglaucomapatientawarenessofvisualfieldloss